| Original language | English |
|---|---|
| Pages (from-to) | 99-105 |
| Number of pages | 7 |
| Journal | Journal of Controlled Release |
| Volume | 146 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 17 Aug 2010 |
| Externally published | Yes |
Funding
This work was supported by FUN (University of Navarra Foundation), Government of Navarra (Department of Education) and Bancaja Foundation, the EC funded project GIANT, DFG SFB486 and SPP1230, and the DFG Excellence Cluster "Nanosystems Initiative Munich" (NIM). Melinda Kiss is gratefully acknowledged for technical assistance.
Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry
Keywords
- PAMAM dendrimer
- Tumor targeting
- CpG free plasmid
- GENE DELIVERY
- IN-VIVO
- LINEAR POLYETHYLENIMINE
- DNA COMPLEXES
- VITRO
- POLYPLEXES
- VECTOR
- LUNG
- TRANSFECTION
- DYNAMICS
Fingerprint
Dive into the research topics of 'Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver